Diana Isaacs
The Diabetes Pharmacist, @ClevelandClinic, #Diabetes Advocate, Speaker, Podcast host, ADCES 2020 Diabetes Care & Education Specialist of the Year, posts my own
Articles
-
1 week ago |
hcplive.com | Diana Isaacs |Natalie Bellini
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, break down a pair of studies examining the effects of semaglutide...
-
1 week ago |
hcplive.com | Diana Isaacs |Natalie Bellini
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! 00:00:00 Introduction 00:02:18 Inspiration Behind the Paper 00:04:12 Challenges in Implementing T1D Screening 00:07:32 Educating Providers and Overcoming Barriers 00:09:32 Addressing Misdiagnosis of Diabetes 00:12:01 Inpatient Screening Practices 00:16:13 Support and Resources for Patients with Positive Antibodies 00:20:01 Conclusion and Final Thoughts In this episode of Diabetes Dialogue, hosts Diana...
-
2 weeks ago |
consultantlive.com | Natalie Bellini |Diana Isaacs
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explored two key trial updates in type 2 diabetes (T2D) care at the...
-
2 weeks ago |
hcplive.com | Natalie Bellini |Diana Isaacs
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explored two key trial updates in type 2 diabetes (T2D) care at the...
-
2 weeks ago |
t1dexchange.org | Diana Isaacs
If you live with diabetes, you’re likely familiar with cholesterol-lowering medications called “statins.” While initially used to treat high cholesterol, researchers also found they reduced the risk of heart disease in people at higher risk with normal cholesterol levels. That’s why your provider may have had a conversation with you about these drugs. Simply having diabetes can increase the risk of heart attack and stroke.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 3K
- Tweets
- 2K
- DMs Open
- Yes
RT @nerdabetic: Medtronic’s Simplera Sync CGM is approved by the FDA. It’s Medtronic’s new all-in-one CGM which has been out in Europe for…
RT @HCPLiveNews: The latest #DiabetesDialogue takes a deep dive into 2 studies from #ACC25, hear from @DianaMIsaacs and @Natalie_Bellini on…
It was so great to have the expert and do author of this new paper @RifkaSchulmanMD talk about screening for T1D in clinical practice.
Really enjoyed making this podcast with @DianaMIsaacs and @natalie_bellini on bringing #T1D screening to clinical practice as well as discussing efforts at @NorthwellHealth @HofNorthwellDOM @YTobiHarris